CN Stock MarketDetailed Quotes

301331 Enwei Pharmaceutical

Watchlist
  • 27.34
  • +0.25+0.92%
Market Closed Nov 11 15:00 CST
2.81BMarket Cap79.48P/E (TTM)

About Enwei Pharmaceutical Company

The company was founded in 1986 and is mainly engaged in R&D, production and sales of proprietary Chinese medicines and chemicals. It is committed to combining traditional Chinese medicine with modern medical technology to establish a traditional Chinese medicine industry with deep Chinese characteristics around life science. Listed on A-shares on the Shenzhen Stock Exchange on September 21, 2022. The company is mainly engaged in R&D, production and sales of proprietary Chinese medicines and chemicals, focusing on gynecological products, pediatric medicine, respiratory medicine and other fields. Main products: Jieryin lotion, Huajiji oral liquid, Shanmai spleen oral solution, Agastache Zhengqi Tonic, Liuwei Dihuang capsules, compound Yinqiao aminamine capsules, compound aminophenolamine tablets.

Company Profile

Short Name-A恩威医药
Symbol-A301331
Company NameEnwei Pharmaceutical Co.,Ltd.
Listing DateSep 21, 2022
Issue Price29.80
Shares Offered17.54M share(s)
FoundedMay 19, 2005
Legal Representativeyongjiang xue
General Managergang xue
Secretarydawei hu
Accounting FirmShinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
Securities Representativeyongbao tan
Legal CounselBeijing Jindu (Chengdu) Law Firm
Employees805
Phone028-85887067
Office AddressNo. 458, Section 3, Shuanghua Road, Shuangliu District, Chengdu, Sichuan
Zip Code610200
Registered AddressEnwei Building, Chuangye Avenue, Aba District, Economic Development Zone, Changdu City, Tibet Autonomous Region
Fax028-85887067
Emailir_ew@enwei.com.cn
Websitehttp://www.enwei.com.cn
Business License542100200000777
BusinessLicensed projects: Pharmaceutical wholesale; pharmaceutical production; drug contract production; Class III medical device management (projects subject to approval by law, business activities can only be carried out after approval by relevant departments) General projects: Class II medical device sales; sales of first-class medical devices; sales of disinfectants (excluding hazardous chemicals); sales of hygiene products and disposable medical products; real estate purchases of Chinese herbal medicines (excluding Chinese medicine tablets); Chinese herbal medicine acquisition; medical research and experimental development; technical services, technology development, technical consultation, technical exchange, technology exchange, technology transfer, technology promotion; non-residential real estate leasing (above) (The scope of business is subject to approval by the registration authority)

Company Executives

  • Name
  • Position
  • Salary
  • yongjiang xue
  • Chairman, directors, Chief Executive Officer (CEO), Member of the Nomination and Remuneration Committee, Chairman of the Strategy and Development Committee
  • 1.40M
  • gang xue
  • Vice Chairman, Directors, General Manager
  • 726.00K
  • yan zhuang
  • Directors, Deputy General Manager, Member of the Strategy and Development Committee
  • 422.00K
  • weihong xue
  • Directors, Audit Committee Member
  • --
  • ya liu
  • Independent Directors, Chairman of the Audit Committee
  • --
  • gang peng
  • Independent Directors, Audit Committee Member, Chairman of the Nomination and Remuneration Committee
  • --
  • chun li
  • Independent Directors, Member of the Strategy and Development Committee, Member of the Nomination and Remuneration Committee
  • --
  • dawei hu
  • Board Secretary, VP, Chief Financial Officer
  • 443.70K
  • yongbao tan
  • Securities Affairs Representative
  • --
  • zhanghong du
  • Chairman of the Supervisory Board, Auditors
  • 120.30K
  • li yi
  • Auditors
  • --
  • lei chen
  • VP
  • 471.00K
  • li liu
  • Employee Supervisors
  • 147.80K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data